Specialized Medical Company (TADAWUL:4019)
Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
19.30
-0.20 (-1.03%)
At close: Dec 8, 2025

TADAWUL:4019 Income Statement

Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
1,4601,4401,3681,2091,053867.24
Revenue Growth (YoY)
-1.72%5.24%13.18%14.77%21.44%-
Cost of Revenue
1,1171,0551,019930824.89704.07
Gross Profit
342.93384.85348.96278.66228.24163.16
Selling, General & Admin
148.51154.55134.38150.91159.04108.12
Operating Expenses
148.51154.55134.38150.91159.04108.12
Operating Income
194.41230.3214.58127.7569.255.05
Interest Expense
-43.04-44.98-48.46-29.82-18.89-15.39
Other Non Operating Income (Expenses)
17.0710.628.529.138.988.13
EBT Excluding Unusual Items
168.44195.95174.65107.0559.2947.79
Gain (Loss) on Sale of Assets
-2.29-2.290.050.06--
Pretax Income
166.14193.66174.7107.1259.2947.79
Income Tax Expense
7.748.4464.153.321.77
Net Income
158.4185.22168.7102.9655.9746.02
Net Income to Common
158.4185.22168.7102.9655.9746.02
Net Income Growth
-27.36%9.79%63.84%83.97%21.62%-
Shares Outstanding (Basic)
250250858599
Shares Outstanding (Diluted)
250250858599
Shares Change (YoY)
19.76%194.12%-900.00%--
EPS (Basic)
0.630.741.981.216.585.41
EPS (Diluted)
0.630.741.981.216.585.41
EPS Growth
-39.34%-62.67%63.84%-81.60%21.62%-
Free Cash Flow
329.45289.52160.53116.6-159.38-2.68
Free Cash Flow Per Share
1.321.161.891.37-18.75-0.32
Gross Margin
23.48%26.73%25.51%23.05%21.67%18.81%
Operating Margin
13.31%16.00%15.69%10.57%6.57%6.35%
Profit Margin
10.85%12.87%12.33%8.52%5.31%5.31%
Free Cash Flow Margin
22.56%20.11%11.73%9.65%-15.13%-0.31%
EBITDA
257.08288.77273.08202.59141.55110.46
EBITDA Margin
17.60%20.06%19.96%16.76%13.44%12.74%
D&A For EBITDA
62.6658.4758.4974.8572.3555.42
EBIT
194.41230.3214.58127.7569.255.05
EBIT Margin
13.31%16.00%15.69%10.57%6.57%6.35%
Effective Tax Rate
4.66%4.36%3.44%3.88%5.60%3.70%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.